False Claims
November 29, 2017
Aegerion Pharmaceuticals Inc., a Cambridge, Massachusetts-based subsidiary of Novelion Therapeutics Inc., has agreed to plead guilty to charges relating to its prescription drug, Juxtapid, the Justice Department announced.
As charged in a criminal information filed in September, Aegerion introduced Juxtapid into interstate commerce that was misbranded because, among...
Search Our Site
Subscribe to Our Blogs
Sign up for our newsletter to keep up-to-date with the latest important news from The Chanler Group
Contact Our Team
Use our online contact form, or visit our offices page for more details on how to reach us.
Want to apply for a grant? Check out our Grant Seeker FAQ.
If you want to contact a whistleblower attorney, please take a look at our Whistleblower Questionnaire.